Invention Grant
- Patent Title: MECP2E1 gene
-
Application No.: US11352153Application Date: 2006-02-09
-
Publication No.: US07670773B2Publication Date: 2010-03-02
- Inventor: Berge A. Minassian , John B. Vincent
- Applicant: Berge A. Minassian , John B. Vincent
- Applicant Address: CA Toronto, Ontario CA Toronto, Ontario
- Assignee: Centre for Addiction and Mental Health,The Hospital for Sick Children
- Current Assignee: Centre for Addiction and Mental Health,The Hospital for Sick Children
- Current Assignee Address: CA Toronto, Ontario CA Toronto, Ontario
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The invention is a novel MECP2E1 splice variant and its corresponding polypeptide. The invention also includes methods of using these nucleic acid sequences and proteins in medical diagnosis and treatment of neuropsychiatric disorders or development disorders.
Public/Granted literature
- US20060194257A1 MECP2E1 gene Public/Granted day:2006-08-31
Information query
